Skip to Main Content

Chapter 2 elaborates a politics of civil society advocacy against unethical clinical trials in India as it developed through public scandal. It focuses upon a study conducted to facilitate the rollout of the human papilloma virus (HPV) vaccine into India’s national immunization program, which generated enormous controversy and became a fulcrum around which a broader politics concerned with clinical trials in India emerged. This raises questions not just about relationships between health, value, and politics, but also of the configuration of epidemiological knowledge and technocratic forms of governance within these relationships.

Don't already have an account? Register
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal